Form 4: Waystar Holding Corp. Executive T. Craig Bridge Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


T. Craig Bridge, Chief Transformation Officer of Waystar Holding Corp., reports the acquisition of restricted stock units and stock options.

Summary

  • T. Craig Bridge, Chief Transformation Officer of Waystar Holding Corp., filed a Form 4 detailing changes in beneficial ownership.
  • On June 10, 2024, Bridge acquired 152,173 shares of Common Stock through a grant of restricted stock units (RSUs) at a price of $0.
  • These RSUs vest in five substantially equal annual installments starting June 6, 2025.
  • Each RSU represents a contingent right to receive one share of Common Stock upon settlement.
  • As of June 10, 2024, Bridge beneficially owns 204,004 shares of Common Stock, including unvested RSUs.
  • On May 1, 2024, Bridge was granted options to purchase 48,400 shares of Common Stock at an exercise price of $37.20, vesting in three equal annual installments commencing May 1, 2025.
  • On June 6, 2024, Bridge was granted options to purchase 380,434 shares of Common Stock at an exercise price of $21.50, vesting in five equal annual installments commencing June 6, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The grants suggest confidence, but it's standard practice.

Positives

  • The grant of RSUs and stock options to a key executive like the Chief Transformation Officer suggests an incentive alignment with the company's long-term performance.
  • The vesting schedules encourage the executive's continued service and contribution to the company's success.

Future Outlook

The executive's holdings will increase as the RSUs and stock options vest over the coming years, contingent on continued employment and achievement of vesting conditions.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company executives and their confidence in the company's future prospects.

Comparison to Industry Standards

  • Stock option and RSU grants are a common form of executive compensation in the tech and healthcare industries, used to align management interests with shareholder value.
  • Vesting schedules are typically structured over 3-5 years, similar to the vesting terms reported in this filing.
  • The size of the grants is relative to the executive's role and the company's overall compensation strategy; benchmarking against peer companies would provide further context.

Stakeholder Impact

  • Shareholders may view the grants as a positive sign of aligning executive interests with company performance.
  • Employees may see the grants as a reflection of the company's commitment to rewarding key personnel.

Key Dates

DateDescription
05/01/2024Grant of stock options to purchase 48,400 shares at $37.20, vesting in three annual installments commencing May 1, 2025
05/15/2024Effective date of the 0.605-for-1 reverse stock split
06/06/2024Grant of stock options to purchase 380,434 shares at $21.50, vesting in five annual installments commencing June 6, 2025
06/10/2024Grant of 152,173 restricted stock units (RSUs), vesting in five annual installments commencing June 6, 2025
06/12/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.